Pernix To Present At Cowen and Company Health Care Conference
Posted on 03/09/2010
MAGNOLIA, TX, March 9, 2010 -- Pernix Therapuetics Holdings, Inc. (NYSE Amex: PTX) (“the Company”) today announced that the Company will present at the Cowen and Company 30th Annual Health Care Conference at the Marriott Copley Place in Boston.
The Company’s presentation is scheduled for Wednesday, March 10, 2010 at 9:30 a.m. EST, and will be delivered by Cooper Collins, Chief Executive Officer of Pernix. An archived webcast, in addition to presentation slides, will be available on the Investor Relations page of the Pernix website at www.pernixtx.com.
About Pernix Therapuetics Holdings, Inc.
Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company primarily focused on serving the needs of the pediatric marketplace. Commercially-proven branded product families include Brovex, Aldex, Pediatex, ReZyst, QuinZyme and Z-Cof. The company was originally founded in 1999 and is based in the Houston, TX metropolitan area. Additional information is available on the Pernix website at www.pernixtx.com.
Cautionary Notice Regarding Forward-Looking Statements
The Company wishes to caution readers not to place undue reliance on any forward-looking statements, which speak only as of the date made. No assurances can be given regarding the future performance of the Company. The Company wishes to advise readers that factors could affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements.
The Company does not undertake, and specifically declines any obligation, to publicly release the result of any revisions which may be made to any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.